KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.58 $2.30 Thursday, 25th Apr 2024 CTMX stock ended at $1.60. This is 1.84% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.54% from a day low at $1.58 to a day high of $1.64.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Mar 20, 2024 $2.20 $2.28 $2.12 $2.27 650 024
Mar 19, 2024 $2.01 $2.24 $2.00 $2.18 915 232
Mar 18, 2024 $2.09 $2.10 $1.96 $2.02 764 133
Mar 15, 2024 $2.05 $2.16 $2.02 $2.07 476 100
Mar 14, 2024 $2.10 $2.12 $1.93 $2.06 1 089 344
Mar 13, 2024 $2.12 $2.17 $2.07 $2.10 663 371
Mar 12, 2024 $2.02 $2.20 $1.91 $2.15 2 033 237
Mar 11, 2024 $2.52 $2.56 $2.46 $2.51 817 782
Mar 08, 2024 $2.52 $2.67 $2.49 $2.50 570 160
Mar 07, 2024 $2.73 $2.73 $2.44 $2.56 1 184 645
Mar 06, 2024 $2.78 $2.79 $2.50 $2.70 1 251 273
Mar 05, 2024 $2.70 $2.85 $2.69 $2.72 2 361 748
Mar 04, 2024 $2.70 $2.86 $2.55 $2.74 2 451 889
Mar 01, 2024 $2.42 $2.78 $2.36 $2.65 2 565 284
Feb 29, 2024 $2.44 $2.62 $2.39 $2.45 2 026 306
Feb 28, 2024 $2.18 $2.74 $2.17 $2.54 6 824 265
Feb 27, 2024 $1.66 $2.44 $1.66 $2.25 9 585 523
Feb 26, 2024 $1.48 $1.65 $1.46 $1.65 506 761
Feb 23, 2024 $1.46 $1.52 $1.43 $1.50 1 010 269
Feb 22, 2024 $1.47 $1.50 $1.44 $1.48 135 289
Feb 21, 2024 $1.46 $1.47 $1.45 $1.45 81 048
Feb 20, 2024 $1.47 $1.50 $1.46 $1.47 105 291
Feb 16, 2024 $1.47 $1.51 $1.46 $1.47 147 894
Feb 15, 2024 $1.50 $1.53 $1.46 $1.50 216 856
Feb 14, 2024 $1.45 $1.49 $1.42 $1.49 158 232
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT